Cardiovascular Reparative Medicine and Tissue Engineering (CRMTE) aims to develop future technologies and therapeutic strategies that will serve as treatment for cardiovascular disease. CRMTE includes ...

In the rapidly evolving arena of regenerative science, two peptides – BPC‑157 (Body Protection Compound‑157) and TB‑500 (a short‑chain analogue of thymosin β4) – have garnered increasing interest for ...

Bladder tissue engineering aims to restore or replace damaged bladder tissue using a combination of biomaterials, stem cell technology, and controlled delivery of bioactive agents. This ...

Tissue engineering and regenerative medicine have shown significant potential for repairing and regenerating damaged tissues and can be used to provide personalized treatment plans, with broad ...

Katie Weimer figured out a way to make regenerative tissue to bring hope to breast cancer survivors around the world. In the lab of her Colorado startup, she is building “scaffolds” from advanced, ...

In recent years, there have been tremendous advances in tissue engineering, the field of biomaterials research and development that combines living cells with 3D microstructures and biologically ...

Neural tissue engineering aims to mimic the brain's complex environment, the extracellular matrix, which supports nerve cell growth, development, and proper connectivity. This environment is carefully ...

Organ failure impacts millions of patients each year and costs hundreds of billions of US Dollars. Over the last 30 years, scientists have utilized a combination of tools, methods, and molecules of ...

These fields aim to facilitate healing and restore lost function in damaged or diseased tissues and organs by integrating scaffolds, cells, and biological signaling molecules. This combination aims to ...

Researchers have developed a method to direct stem cells to form specific structures. By triggering the expression of specific genes in mouse embryonic stem cells, synthetic organizer cells were ...

A new type of tissue model that more accurately mimics the architecture of the liver could help develop drugs to treat MASLD.